The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, described it as "a common-sense approach" intended "to bring more cures and ...

WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...

WASHINGTON - The U.S. Food and Drug Administration plans to approve a new use for the generic drug leucovorin as a treatment for kids with autism. Trump, Health and Human Services Secretary Robert F.

WASHINGTON, D.C. — The U.S. Food and Drug Administration announced two major actions last week: making its internal drug application checklists public to improve transparency and issuing the ...

Earlier this month, the U.S. Food and Drug Administration (FDA) launched its most sweeping direct-to-consumer (DTC) advertising crackdown in years. This wave of compliance activity is unprecedented, ...